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Fig. S1
1 H NMR spectrum of compound 15a (measured in CDCl3). 
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1 H NMR spectrum of compound 15c (measured in CDCl3).
Fig. S6
13 C NMR spectrum of compound 15c (measured in CDCl3). 
Compound 16c (4Z,10S)-12-Acetyl-4-{[(1R,5S)-dimethylbicyclo[3.1.1]hept-2-en-3-yl]methylidene}-
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1 H NMR spectrum of compound 15g (measured in CDCl3). 
